Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IV Ensure in Patients Receiving OPAT

NCT06623318 is registered in ClinicalTrials.gov with IV Ensure as lead sponsor.

NCT NCT06623318
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06623318 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IV Ensure in Patients Receiving OPAT
Lead sponsor
IV Ensure
Phase
Not applicable
Overall status
Recruiting
Start date
August 23, 2023
Completion date
November 30, 2024
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

determine if adherence rates with iv antibiotics in opat have a correlation to hospital readmission rates